Artal Group as of June 30, 2022
Portfolio Holdings for Artal Group
Artal Group holds 134 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Argenx Se Sponsored Adr (ARGX) | 8.1 | $152M | 400k | 378.88 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 7.1 | $132M | 71M | 1.86 | |
| Beigene Sponsored Adr (ONC) | 5.6 | $105M | 650k | 161.85 | |
| Ww Intl | 5.1 | $95M | 15M | 6.39 | |
| Seagen | 5.0 | $93M | 525k | 176.94 | |
| Alnylam Pharmaceuticals (ALNY) | 4.7 | $88M | 600k | 145.85 | |
| Mirati Therapeutics | 3.9 | $74M | 1.1M | 67.13 | |
| Bellus Health Com New | 3.5 | $65M | 7.0M | 9.24 | |
| Fate Therapeutics (FATE) | 3.4 | $64M | 2.6M | 24.78 | |
| Cytokinetics Com New (CYTK) | 2.7 | $50M | 1.3M | 39.29 | |
| Scholar Rock Hldg Corp (SRRK) | 2.6 | $48M | 8.8M | 5.49 | |
| Citigroup Com New Call Option (C) | 2.5 | $46M | 1.0M | 45.99 | |
| Amicus Therapeutics (FOLD) | 2.3 | $43M | 4.0M | 10.74 | |
| Seer Com Cl A (SEER) | 2.3 | $43M | 4.8M | 8.95 | |
| Cerevel Therapeutics Hldng I (CERE) | 2.1 | $40M | 1.5M | 26.44 | |
| Igm Biosciences (IGMS) | 2.0 | $37M | 2.1M | 18.03 | |
| Morphic Hldg (MORF) | 1.9 | $36M | 1.7M | 21.70 | |
| Krystal Biotech (KRYS) | 1.8 | $33M | 500k | 65.66 | |
| Direxion Shs Etf Tr Sp Biotch Bl New Call Option | 1.4 | $27M | 4.0M | 6.74 | |
| Foghorn Therapeutics (FHTX) | 1.2 | $23M | 1.7M | 13.60 | |
| Springworks Therapeutics (SWTX) | 1.2 | $22M | 900k | 24.62 | |
| Gossamer Bio (GOSS) | 1.1 | $20M | 2.4M | 8.37 | |
| Kymera Therapeutics (KYMR) | 1.1 | $20M | 1.0M | 19.69 | |
| Kura Oncology (KURA) | 1.0 | $19M | 1.1M | 18.33 | |
| Eqrx | 1.0 | $19M | 4.0M | 4.69 | |
| Schrodinger (SDGR) | 1.0 | $19M | 700k | 26.41 | |
| Generation Bio | 1.0 | $19M | 2.8M | 6.56 | |
| Erasca (ERAS) | 0.9 | $18M | 3.2M | 5.57 | |
| Denali Therapeutics (DNLI) | 0.9 | $18M | 600k | 29.43 | |
| Replimune Group (REPL) | 0.8 | $16M | 900k | 17.48 | |
| Sage Therapeutics (SAGE) | 0.8 | $15M | 450k | 32.30 | |
| Intellia Therapeutics (NTLA) | 0.8 | $14M | 275k | 51.76 | |
| Evotec Sponsored Ads (EVO) | 0.7 | $14M | 1.1M | 11.98 | |
| Relay Therapeutics (RLAY) | 0.6 | $12M | 700k | 16.75 | |
| Mersana Therapeutics | 0.5 | $10M | 2.2M | 4.62 | |
| Aurinia Pharmaceuticals (AUPH) | 0.5 | $10M | 1.0M | 10.05 | |
| Repare Therapeutics Ord (RPTX) | 0.5 | $9.8M | 700k | 13.99 | |
| Wave Life Sciences SHS (WVE) | 0.5 | $9.8M | 3.0M | 3.25 | |
| I Mab Sponsored Ads (IMAB) | 0.5 | $9.6M | 850k | 11.30 | |
| Talaris Therapeutics | 0.5 | $9.3M | 2.1M | 4.51 | |
| Allovir (ALVR) | 0.5 | $9.1M | 2.3M | 3.90 | |
| Omega Therapeutics (OMGAQ) | 0.5 | $8.6M | 2.3M | 3.80 | |
| Iteos Therapeutics | 0.4 | $8.2M | 400k | 20.60 | |
| Atara Biotherapeutics | 0.4 | $7.8M | 1.0M | 7.79 | |
| Omega Alpha Spac Cl A | 0.4 | $7.4M | 750k | 9.85 | |
| Ikena Oncology (IKNA) | 0.4 | $6.9M | 1.5M | 4.43 | |
| Selecta Biosciences | 0.3 | $6.4M | 4.9M | 1.31 | |
| Verve Therapeutics (VERV) | 0.3 | $6.1M | 400k | 15.28 | |
| Y Mabs Therapeutics | 0.3 | $6.1M | 400k | 15.13 | |
| Exscientia Ads (EXAI) | 0.3 | $6.0M | 550k | 10.89 | |
| Agenus Com New | 0.3 | $5.8M | 3.0M | 1.94 | |
| Ambrx Biopharma Sponsored Ads | 0.3 | $5.7M | 2.2M | 2.65 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.3 | $5.7M | 2.3M | 2.52 | |
| Kronos Bio | 0.3 | $5.6M | 1.5M | 3.64 | |
| Design Therapeutics (DSGN) | 0.3 | $5.6M | 400k | 14.00 | |
| Ovid Therapeutics (OVID) | 0.3 | $5.4M | 2.5M | 2.15 | |
| Oatly Group Ab Sponsored Ads | 0.3 | $5.2M | 1.5M | 3.46 | |
| Sqz Biotech (SQZB) | 0.3 | $5.1M | 1.6M | 3.18 | |
| Alpine Immune Sciences | 0.3 | $5.0M | 593k | 8.51 | |
| Marinus Pharmaceuticals Com New | 0.3 | $4.8M | 1.0M | 4.84 | |
| Contrafect Corp Com New | 0.2 | $4.6M | 1.5M | 3.07 | |
| Leap Therapeutics | 0.2 | $4.6M | 4.0M | 1.15 | |
| Lyell Immunopharma | 0.2 | $4.6M | 700k | 6.52 | |
| Black Diamond Therapeutics (BDTX) | 0.2 | $4.0M | 1.6M | 2.46 | |
| Alx Oncology Hldgs (ALXO) | 0.2 | $4.0M | 500k | 8.09 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.2 | $3.9M | 1.0M | 3.72 | |
| Syros Pharmaceuticals | 0.2 | $3.9M | 4.0M | 0.96 | |
| Sea Sponsored Ads (SE) | 0.2 | $3.8M | 58k | 66.85 | |
| Nanobiotix Sponsored Ads (NBTX) | 0.2 | $3.8M | 1.0M | 3.80 | |
| Portage Fintech Acquisitn Class A Ord Shs | 0.2 | $3.7M | 380k | 9.75 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.2 | $3.7M | 450k | 8.14 | |
| Avidity Biosciences Ord (RNA) | 0.2 | $3.6M | 250k | 14.53 | |
| Ac Immune Sa SHS (ACIU) | 0.2 | $3.6M | 1.0M | 3.61 | |
| Dyne Therapeutics (DYN) | 0.2 | $3.6M | 525k | 6.87 | |
| Adverum Biotechnologies | 0.2 | $3.6M | 3.0M | 1.20 | |
| Aptinyx | 0.2 | $3.4M | 6.1M | 0.56 | |
| Stoke Therapeutics (STOK) | 0.2 | $3.3M | 250k | 13.21 | |
| Adagio Therapeutics (IVVD) | 0.2 | $3.3M | 1.0M | 3.28 | |
| Cullinan Oncology (CGEM) | 0.2 | $3.2M | 250k | 12.82 | |
| Rubius Therapeutics | 0.2 | $3.1M | 3.7M | 0.85 | |
| Hookipa Pharma Inc equity | 0.2 | $3.0M | 1.8M | 1.63 | |
| Praxis Precision Medicines I | 0.2 | $2.9M | 1.2M | 2.45 | |
| Vigil Neuroscience (VIGL) | 0.2 | $2.9M | 1.1M | 2.58 | |
| Mirion Technologies Com Cl A (MIR) | 0.2 | $2.9M | 500k | 5.76 | |
| Vor Biopharma (VOR) | 0.1 | $2.7M | 550k | 4.97 | |
| Cincor Pharma | 0.1 | $2.6M | 137k | 18.84 | |
| Sana Biotechnology (SANA) | 0.1 | $2.6M | 400k | 6.43 | |
| Immunic (IMUX) | 0.1 | $2.4M | 700k | 3.47 | |
| Zymeworks | 0.1 | $2.4M | 450k | 5.30 | |
| Bridgebio Pharma (BBIO) | 0.1 | $2.3M | 250k | 9.08 | |
| Tcr2 Therapeutics Inc cs | 0.1 | $2.2M | 750k | 2.90 | |
| Instil Bio | 0.1 | $2.1M | 450k | 4.62 | |
| Senti Biosciences Ord | 0.1 | $2.1M | 1.1M | 1.96 | |
| Adagene Ads (ADAG) | 0.1 | $2.1M | 1.0M | 2.07 | |
| Immutep Sponsored Ads (IMMP) | 0.1 | $2.0M | 1.0M | 2.03 | |
| 111 Ads | 0.1 | $2.0M | 966k | 2.06 | |
| Neximmune | 0.1 | $1.9M | 1.2M | 1.61 | |
| Graphite Bio | 0.1 | $1.9M | 700k | 2.75 | |
| Harpoon Therapeutics | 0.1 | $1.9M | 1.0M | 1.91 | |
| Fusion Pharmaceuticals | 0.1 | $1.9M | 750k | 2.49 | |
| Solid Biosciences | 0.1 | $1.8M | 3.0M | 0.62 | |
| Gritstone Oncology Ord (GRTSQ) | 0.1 | $1.8M | 750k | 2.42 | |
| Oric Pharmaceuticals (ORIC) | 0.1 | $1.8M | 400k | 4.48 | |
| Mereo Biopharma Group Ads (MREO) | 0.1 | $1.7M | 1.5M | 1.12 | |
| Cardiff Oncology (CRDF) | 0.1 | $1.7M | 750k | 2.20 | |
| 23andme Holding Class A Com | 0.1 | $1.6M | 661k | 2.48 | |
| Kinnate Biopharma | 0.1 | $1.6M | 125k | 12.61 | |
| Cyclerion Therapeutics | 0.1 | $1.5M | 2.8M | 0.55 | |
| Axcella Health Inc equity | 0.1 | $1.4M | 713k | 2.03 | |
| Amylyx Pharmaceuticals (AMLX) | 0.1 | $1.4M | 75k | 19.27 | |
| Xilio Therapeutics (XLO) | 0.1 | $1.3M | 450k | 2.92 | |
| Aravive | 0.1 | $1.3M | 1.3M | 0.99 | |
| Curis Com New | 0.1 | $1.3M | 1.3M | 0.98 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.1 | $1.3M | 111k | 11.53 | |
| Olema Pharmaceuticals (OLMA) | 0.1 | $1.1M | 261k | 4.07 | |
| Orchard Therapeutics Ads | 0.1 | $1.1M | 1.8M | 0.58 | |
| Mei Pharma Com New | 0.0 | $605k | 1.0M | 0.60 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.0 | $590k | 200k | 2.95 | |
| Codiak Biosciences | 0.0 | $576k | 200k | 2.88 | |
| Caribou Biosciences (CRBU) | 0.0 | $572k | 105k | 5.43 | |
| Hippo Holdings | 0.0 | $527k | 600k | 0.88 | |
| Corvus Pharmaceuticals (CRVS) | 0.0 | $495k | 500k | 0.99 | |
| Metacrine Ord | 0.0 | $462k | 925k | 0.50 | |
| Mink Therapeutics | 0.0 | $408k | 290k | 1.41 | |
| Yumanity Therapeutics | 0.0 | $396k | 217k | 1.82 | |
| Cleveland-cliffs (CLF) | 0.0 | $384k | 25k | 15.36 | |
| United Sts Nat Gas Unit Par | 0.0 | $380k | 20k | 19.00 | |
| Applied Therapeutics (APLT) | 0.0 | $379k | 400k | 0.95 | |
| Spero Therapeutics (SPRO) | 0.0 | $371k | 500k | 0.74 | |
| Bath & Body Works In (BBWI) | 0.0 | $337k | 13k | 26.96 | |
| Sigilon Therapeutics | 0.0 | $229k | 276k | 0.83 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.0 | $110k | 225k | 0.49 | |
| Astria Therapeutics (ATXS) | 0.0 | $100k | 33k | 3.00 | |
| Kaleido Biosciences Ord (KLDO) | 0.0 | $31k | 501k | 0.06 |
